ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.6K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
13K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
47
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
405K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.3K
|
405K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.6K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.6K
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.6K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.6K
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.6K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.6K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.7K |
2.8M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.7K |
2.8M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.6K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
405K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.3K
|
405K
|
1
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
1.9K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
1.9K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL June 2024 Quarterly Report and Appendix 4C
|
|
whytee
|
6 |
1.9K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
1.9K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
6 |
2.1K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
6
|
2.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.2M |
7 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.2M |
11 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
11
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
13K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
13K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.2M |
9 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
9
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
16 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
189
|
62K
|
16
|
|
ASX - By Stock
|
PNV |
Re:
We`re having a good time
|
|
whytee
|
2 |
1.3K |
13 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
2
|
1.3K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
41K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
41K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.7K |
2.8M |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.7K |
2.8M |
9 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
9
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
7 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
189
|
62K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
whytee
|
625 |
218K |
5 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
625
|
218K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
6 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
189
|
62K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
whytee
|
18K |
6.9M |
0 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
18K
|
6.9M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
13 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
189
|
62K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
whytee
|
943 |
406K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
406K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
whytee
|
189 |
62K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
189
|
62K
|
2
|
|